(Press-News.org) Contact information: Andrew Thompson
andrew@landesbioscience.com
Landes Bioscience
Erythropoietin and the regulation of cancer stem cell growth and survival
In recent years, non-hematopoietic effects of erythropoietin (EPO), via its binding to the EPO receptor in non-hematopoietic tissues, including cancerous tissues, has been reported by many different laboratories worldwide. However, it remains controversial concerning whether EPO, particularly recombinant EPO that is used to treat anemia in patients, may promote cancer cell proliferation and survival.
In this paper, the authors show evidence indicating the presence of autocrine/paracrine EPO in the conditioned medium of cultured breast cancer cells and a functional role of an EPO-EPOR autocrine/paracrine loop in regulating tumor cell invasion and migration, and the stem-ness of breast cancer cells. The data support a novel paradigm wherein autocrine/paracrine EPO may regulate tumorigenesis of breast cancer via stimulating a small percentage of stem-like cancer cells or tumor-initiating cells. This mode of EPO action may explain why some studies reported in literature failed to demonstrate a pro-proliferative and pro-survival role of EPO in cancer cells when whole-populations of cancer cells were analyzed in these studies.
For the full report by Liang et al. in Cancer Biology & Therapy, visit the following link: https://www.landesbioscience.com/journals/cbt/article/26717/
INFORMATION:
Published by Landes Bioscience since 2002, Cancer Biology & Therapy publishes relevant and high-impact original research with a special focus on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. Established in 2002, Landes Bioscience is an Austin, Texas-based publisher of biology research journals and books. For more information on Landes Bioscience, please visit http://www.landesbioscience.com/.
END
Development of a novel dual JAK/Src kinase inhibitor
Inhibitors of both JAK and Src kinases represent promising targets for cancer therapeutics because of the central importance of these kinases in tumor cell proliferation and survival. Furthermore, in cancer cells activation ...
Out-of-pocket costs play major role in treatment adherence for cancer patients
The cost of insurance co-payments for cutting-edge pharmaceuticals can vary widely from patient to patient. When the patient's share of prescription costs becomes ...
Ear tubes vs. watchful waiting: Tubes do not improve long-term development
Watchful waiting or ear tube surgery? It is a decision faced by millions of families of children with recurrent or chronic otitis media with effusion (non-infected ...
Including women on convening committees increases women speakers at scientific meetings
Women are currently underrepresented among speakers at scientific meetings, both in absolute terms and relative to their representation among attendees, but a new study suggests ...
'Traffic light' food labels, positioning of healthy items produce lasting choice changes
The use of color-coded "traffic light" food labels and changes in the way popular items are displayed appear to have produced a long-term increase in the choice ...
Boost careers of female scientists: Make sure women help choose meeting speakers
January 7, 2014 — (BRONX, NY) — More women are choosing science careers, yet women are notoriously underrepresented in senior academic positions—often because they ...
Similar characteristics of brain DTI for healthy adult rhesus monkey and young people
Diffusion-tensor imaging can be used to observe the microstructure of brain tissue. Fractional anisotropy reflects the integrity of white matter fibers. Fractional anisotropy of ...
Mannotriose promotes survival of hippocampal neurons
The main component of the Chinese herb Rehmannia, mannotriose, can improve learning and memory. Dr. Lina Zhang and colleagues from Shanghai University of Traditional Chinese Medicine in China used 1 × 10 mol/L ...
Gabapentin inhibits central sensitization during migraine
Gabapentin is a gamma-aminobutyric acid derivative, and was approved for the treatment of neuropathic pain by the U.S. Food and Drug Administration in 2002. However, little evidence is available on the effects ...
